RxDoctor Payments Data

Abbey Aaroe

Family · Canon City, CONPI 1922685189

Payments from drug & device makers

$6,007in general payments, 2019–2025

Across 146 payments — averaging $41.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pacira Pharmaceuticals Incorporated$4K
  • Collegium Pharmaceutical, Inc.$1K
  • Scilex Pharmaceuticals Inc.$218
  • GRT US Holding, Inc.$195
  • AbbVie$130
  • Pfizer$106
  • plus $408 from 12 others

What the payments were for

  • Consulting fees$1,96033%
  • Travel & lodging$1,53726%
  • Food & beverage$2,51042%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,007 in reported general payments places this provider in the 95th percentile of 2,182 family providers in Colorado.

See all family providers in Colorado

Medicare billing

Part B allowed, 2024
$106,950
Medicare patients
158
Services billed
1,102

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BelbucaBuprenorphine Hcl186$146,982
Xtampza ErOxycodone Myristate44$34,368
Nucynta ErTapentadol Hcl16$23,694
ZtlidoLidocaine20$17,931
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl74$16,772
Buprenorphine66$13,742
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen403$10,897
OxycontinOxycodone Hcl23$9,828
MovantikNaloxegol Oxalate18$9,821
Hysingla ErHydrocodone Bitartrate16$6,939
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen200$6,417
Tramadol Hcl ErTramadol Hcl55$3,918
Morphine Sulfate ErMorphine Sulfate92$2,883
Oxycodone Hcl163$2,752
Pregabalin163$2,362

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er, Nucynta Er$1,025$205,043246 claims
Hikma Pharmaceuticals USABuprenorphine-Naloxone, Buprenorphine, Morphine Sulfate$18$31,621179 claims
Scilex Pharmaceuticals Inc.Ztlido$218$17,93120 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,182 family providers in Colorado.

Other family in Canon City

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →